Advanced search
Publication Cover
Clinical Ophthalmology Volume 18, 2024 - Issue
Submit an article Journal homepage
0
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Italian Patient Satisfaction with wAMD Management: SWAN Study Results

Enrico Peiretti1 Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera, Universitaria di Cagliari, Cagliari, ItalyCorrespondence[email protected]
View further author information
,
Chiara Ascardi2 Novartis Farma S.p.A, Milan, ItalyView further author information
,
Francesco Bandello3 Department of Ophthalmology, San Raffaele Scientific Institute, Vita-Salute University, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-3238-9682View further author information
ORCID Icon,
Francesco Boscia4 Department of Medical Science, Neuroscience and Sense Organs, Eye Clinic, University of Bari, Azienda Ospedaliero-Universitaria Policlinico Bari, Bari, ItalyView further author information
,
Monica Varano5 IRCCS G.B. Bietti Foundation, Rome, ItalyView further author information
,
Marta Bartezaghi2 Novartis Farma S.p.A, Milan, ItalyORCID Iconhttps://orcid.org/0009-0009-9400-2157View further author information
ORCID Icon,
Lorenzo De Santi2 Novartis Farma S.p.A, Milan, ItalyView further author information
&
Giovanni Staurenghi6 Eye Clinic, Department of Biomedical and Clinical Sciences, Luigi Sacco Hospital, University of Milan, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-2299-5251View further author information
ORCID Icon show all
Pages 2183-2191 | Received 23 May 2024, Accepted 09 Jul 2024, Published online: 02 Aug 2024

References

  • Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147–1159. doi:10.1016/S0140-6736(18)31550-2
  • Wang Y, Zhong Y, Zhang L, et al. Global incidence, progression, and risk factors of age-related macular degeneration and projection of disease statistics in 30 years: a modeling study. Gerontology. 2022;68(7):721–735. doi:10.1159/000518822
  • Hassell JB, Lamoureux EL, Keeffe JE. Impact of age related macular degeneration on quality of life. Br J Ophthalmol. 2006;90(5):593–596. doi:10.1136/bjo.2005.086595
  • Gohil R, Crosby-Nwaobi R, Forbes A, Burton BJ, Hykin P, Sivaprasad S. Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting. Patient Prefer Adherence. 2016;10:949–955. doi:10.2147/PPA.S105536
  • Chakravarthy U, Harding SP, Rogers CA, et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet. 2013;382(9900):1258–1267. doi:10.1016/S0140-6736(13)61501-9
  • Holz FG, Tadayoni R, Beatty S, et al. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol. 2015;99(2):220–226. doi:10.1136/bjophthalmol-2014-305327
  • Mitchell J, Bradley C. Design and development of the MacTSQ measure of satisfaction with treatment for macular conditions used within the IVAN trial. J Patient Rep Outcomes. 2017;2(1):5. doi:10.1186/s41687-018-0031-z
  • Holz FG, Schmitz-Valckenberg S, Fleckenstein M. Recent developments in the treatment of age-related macular degeneration. J Clin Invest. 2014;124(4):1430–1438. doi:10.1172/JCI71029
  • Mones J, Singh RP, Bandello F, Souied E, Liu X, Gale R. Undertreatment of neovascular age-related macular degeneration after 10 years of anti-vascular endothelial growth factor therapy in the real world: the need for a change of mindset. Ophthalmologica. 2020;243(1):1–8. doi:10.1159/000502747
  • Weldring T, Smith SM. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Serv Insight. 2013;6:61–68.
  • Amoaku WM, Gale RP, Lotery AJ, et al. Treatment satisfaction and well-being in patients with myopic choroidal neovascularization treated with ranibizumab in the REPAIR Study. PLoS One. 2015;10:e0128403.
  • Varano M, Eter N, Winyard S, Wittrup-Jensen KU, Navarro R, Heraghty J. The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD patient and caregiver survey. Clin Ophthalmol. 2016;10:257–267. doi:10.2147/OPTH.S92616
  • Bartlett J, Kotrlik JW, Higgins CC. Organizational research: determining appropriate sample size in survey research. Inform Technol Learn Perform J. 2001;19:43–50.
  • Calles-Monar PS, Sanabria MR, Alonso-Tarancon AM, Coco-Martin RM, Mayo-Iscar A. Modifiable determinants of satisfaction with intravitreal treatment in patients with neovascular age-related macular degeneration. Drugs Aging. 2022;39(5):355–366. doi:10.1007/s40266-022-00937-y
  • Ozdemir S, Finkelstein E, Lee JJ, et al. Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration. PLoS One. 2022;17:e0272301.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.